SOPHARMA AD: Notification concerning the Extraordinary General meeting of shareholders - 14.09.2018

opublikowano: 2018-09-11 13:05

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załącznikw:
3JR_2018_EGM_registration_espi.pdf  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 83 / 2018
Date of issue: 2018-09-11
Short name of the issuer
SOPHARMA AD
Subject
Notification concerning the Extraordinary General meeting of shareholders - 14.09.2018
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) draws attention to the fact that the registration for participation in the Extraordinary General meeting convened on 14 September 2018 will end at 10:45 am to comply with the opening hours announced for the start of the general meeting for the convenience of all shareholders.
Annexes
File Description
3JR_2018_EGM_registration_espi.pdf3JR_2018_EGM_registration_espi.pdf Notification concerning the Extraordinary General meeting of shareholders - 14.09.2018

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2018-09-11 Ognian Donev Executive director